U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07040774) titled 'Natural History of Type 1 Interferonopathies: Insights From a European Cohort' on June 12.
Brief Summary: Type I interferonopathies are rare autoinflammatory disorders caused by genetic defects and associated with significant morbidity and mortality. These diseases are refractory to conventional immunosuppressive therapies. They typically occur in childhood, although disease onset in adulthood has been observed. The clinical spectrum is wide and mainly involves the central nervous system. Joint involvement is also common, and more rarely, haematological features such as cytopenias or immunodeficiency may be observed.
Nearly all pat...